Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-05 · accession 0001213900-23-074336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-06 | 2023-09-05 | CVKD | Pham Quang X | CEO, COB, Dir, 10% | P - Purchase | $0.905 | +40.0K | 3.41M | +1% | +$36.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | P | A | 20,000 | $0.91 | 3,390,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-05 | P | A | 20,000 | $0.9 | 3,410,000 | D | — | — |